Freeline rises on proposal for acquisition of all outstanding shares
18/10/2023 11:50
** Shares of Freeline Therapeutics Holdings FRLN.O rise
~9% to $4.71 premarket
** Co receives non-binding proposal to have its outstanding
shares acquired by Syncona, a Guernsey-based investment company
that funds life sciences companies
** Syncona will acquire all shares of FRLN that aren't
currently owned by Syncona and its affiliates - FRLN
** Adds, Syncona intends to engage in discussions with
Freeline concerning the proposal
** Up to last close, shares down 39.4% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))